Purpose: The purpose of this study is to quantify tumor displacement during real-time PET/CT guided biopsy and to investigate correlations between tumor displacement and false-negative results. Methods: 19 patients who underwent real-time 18 F-FDG PET-guided biopsy and were found positive for malignancy were included in this study under IRB approval. PET/CT images were acquired for all patients within minutes prior to biopsy to visualize the FDG-avid region and plan the needle insertion. The biopsy needle was inserted and a post-insertion CT scan was acquired. The two CT scans acquired before and after needle insertion were registered using a deformable image registration (DIR) algorithm. The DIR deformation vector field (DVF) was used to calculate the mean displacement between the pre-insertion and post-insertion CT scans for a region around the tip of the biopsy needle. For 12 patients one biopsy core from each was tracked during histopathological testing to investigate correlations of the mean displacement between the two CT scans and false-negative or true-positive biopsy results. For 11 patients, two PET scans were acquired; one at the beginning of the procedure, pre-needle insertion, and an additional one with the needle in place. The pre-insertion PET scan was corrected for intraprocedural motion by applying the DVF. The corrected PET was compared with the post-needle insertion PET to validate the correction method. Results: The mean displacement of tissue around the needle between the pre-biopsy CT and the postneedle insertion CT was 5.1 mm (min = 1.1 mm, max = 10.9 mm and SD = 3.0 mm). For mean displacements larger than 7.2 mm, the biopsy cores gave false-negative results. Correcting pre-biopsy PET using the DVF improved the PET/CT registration in 8 of 11 cases. Conclusions: The DVF obtained from DIR of the CT scans can be used for evaluation and correction of the error in needle placement with respect to the FDG-avid area. Misregistration between the pre-biopsy PET and the CT acquired with the needle in place was shown to correlate with false negative biopsy results.
INTRODUCTION
Obtaining an adequate tissue biopsy for microscopic examination is essential for rendering an accurate pathologic diagnosis in cancer patients. However, the success of biopsy procedures is often limited by sampling errors due to imprecise placement of the biopsy needle. Biopsy image guidance using anatomic imaging, e.g., ultrasound or CT, can reduce these errors. In addition, metabolic images like PET can be used to guide interventions for lesions that are not easily seen on anatomic images. 1 Fusion of CT with PET images allows physicians to identify and biopsy a metabolically active lesion before morphologic changes can be observed. 2 In the case of PET/CT guided biopsies the success depends on accurate positioning of the needle relative to the FDG-avid lesion. Until recently, PET/CT-guided biopsies were performed using a preprocedural PET scan acquired several days prior to the biopsy. Such is the investigation by Guralnik et al., who showed that the distance between the location of the needle tip and the lesion highest SUV was significantly higher for falsenegative results (15.4 mm AE 14 mm) than for true-positive (5.9 AE 13.4 mm). 3 To achieve high precision in positioning of the needle, an accurate PET/CT registration is needed. However, changes in size, shape, or metabolic characteristics of the lesion can occur during the time interval between the preprocedural PET and the intraprocedural CT, which can lead to image misregistration. [4] [5] [6] [7] Also, patient position may vary between two acquisitions making registration challenging and suboptimal. 3 More recently and with the availability of PET/CT in the interventional suite, biopsies can be performed with real-time intraprocedural PET/CT guidance, which has been shown to reduce PET/CT misregistration. [8] [9] [10] [11] While real-time PET/CT guidance allows overcoming some of the above limitations, intraprocedural motion and organ displacement due to needle push can still lead to PET/CT misregistration and falsenegative results.
Previous studies sought to evaluate the benefits and accuracy of PET/CT-guided biopsy but the intraprocedural patient and organ motion due to needle push was not measured. Guralnik et al. 3 selected only patients for whom good registration was obtained between the PET/CT scans acquired a few days before and the CT performed during the biopsy procedure. Shyn et al. studied the effect of breathing on PET/CT registration for tumors near the diaphragm during real-time PET/CT guided biopsy but all the scans were acquired before needle insertion. 12 In another study investigating the benefits of PET/CT over CT only guided biopsy, the quality of the PET/CT registration was not mentioned. 7 In this study, a method to evaluate the magnitude of intraprocedural motion leading to PET/CT misregistration during real-time PET/CT-guided biopsies is proposed, as well as a method for motion correction of the PET acquired at the beginning of the procedure. If motion occurs and the registration is not satisfying, a second PET scan can be performed. However, acquiring an additional PET image increases the procedure length, which could potentially lead to a higher risk of complication. Longer procedure times also increase patient's discomfort and in general could result in patient motion. Lastly, correlations between image misregistration and false-negative result were investigated in order to search for a threshold above which the registration is not reliable and a second PET should be acquired to improve the biopsy accuracy.
MATERIALS AND METHODS

2.A. Patients
The method to quantify patient motion and organ shifts due to needle insertion was developed using data from nineteen patients undergoing a real-time PET/CT-guided biopsy under an institutional review board-approved study, which complied with the Health Insurance Portability and Accountability Act. The lesions were not seen on the CT images so the targeting was based on the PET images only. Of these nineteen patients, fifteen were biopsies in the liver, two were in the lung, one was in the spleen, and one was in soft tissue near the left scapula. Biopsy cores were obtained with 18-gauge or 20-gauge needles. The diagnosis was made based on all the extracted cores, with an average of about three cores per patient. All patients included in this study were found positive for malignancy.
2.B. PET/CT guided biopsy procedure
The clinical workflow of patients undergoing real-time PET/CT-guided biopsy is shown in Fig. 1 . A whole-body CT and PET scan (noted CT pre and PET pre ) are acquired at the beginning of the biopsy procedure. CT pre and PET pre are fused to allow for the interventional radiologist to localize the FDG-avid lesion relatively to anatomical structures. The biopsy needle is then inserted with the help of fluoroscopy. An additional CT (referred to as CT needle ) is acquired with the needle in place and fused with PET pre . The position of the needle relatively to the FDG-avid lesion can then be visualized.
A biopsy sample is extracted when the fused PET/CT image shows the needle to be inside the FDG-avid lesion. If that condition is not met, the needle is repositioned and another CT is acquired until adequate positioning is obtained. Immediately after extraction of a biopsy specimen, a rapid on-site evaluation (ROSE) of the specimen is performed by a cytologist. This allows evaluating if the specimen is adequate and if sufficient amount of tissue for diagnosis is obtained. If the first biopsy core is found inadequate by the cytologist, the biopsy needle is repositioned and another core is extracted. Therefore, the number of biopsy specimens extracted from a patient depends on the needle placement i.e., if the needle is placed in the lesion at the first attempt, and on how confident the cytologist is that an adequate core is obtained.
2.C. PET/CT acquisition
PET/CT guided biopsy procedures were performed in an interventional radiology suite on a PET/CT scanner (Discovery 690, GE Healthcare, Waukesha, WI, USA). Patients were injected with 160-225 MBq of 18 F-FDG and patients were under sedation or anesthesia. An initial CT and a free-breathing PET were acquired after an uptake time ranging from 60 to 150 min. The initial PET/CT was used to plan the intervention. In order to reduce the dose to the patient, additional CT scans acquired after needle insertion for a limited region of interest (ranging from 25 to 65 mm in length) and at a higher pitch factor than that for the initial CT. The initial CT was reconstructed to 1.37 x 1.37 x 3.27 mm 3 voxels and additional CTs were reconstructed to 0.877 x 0.877 x 5.00 mm 3 voxels. CT pre was used for PET pre attenuation correction. The initial PET was reconstructed to 5.47 x 5.47 x 3.27 mm 3 voxels. For 11 patients, an additional PET (noted PET needle ) was acquired subsequently to CT needle . The initial CT, CT pre , was used for attenuation correction of PET needle since CT needle can be affected by streak artifact due to the presence of the biopsy needle and due to the lower quality of CT needle . 13 The location of the needle relative to the FDG-avid lesion was visualized on the fused CT needle /PET needle scans [ Fig. 1(b) ].
The PET/CT images were inherently co-registered, using the same local coordinates. For this study, the PET scans were up-sampled from 128 x 128 to 512 x 512 using a linear interpolation to better match the CT images that more accurately identify the position of the biopsy needle.
2.D. Deformable image registration
CT pre was registered to CT needle using a fast free-form deformable registration algorithm 14 implemented in an inhouse research 3-dimensional (3D) treatment planning system (Metropolis). 15 The displacement vector field (DVF) was obtained in 3D and the mean displacement in a volume of interest (130 cm 3 in average) around the needle was calculated (Fig 2) . The volume of interest was manually selected, in order to include the needle tip and the FDG-avid lesion. The size of the volume of interest depends therefore on the inclination of the needle and the size of the lesion. The mean 3D displacement is an estimate of the magnitude of patient and organ motion between CT pre and CT needle in a region around the biopsy needle.
2.E. Misregistration and biopsy adequacy
For the purpose of the study, one of the cores extracted was marked with a tissue marking dye for 12 patients of the 19 patients. This allows tracking this particular core during histopathology examination. The concurrent CT needle scan showing the positioning of the needle right before extraction of the core was recorded for later analysis. The 12 inked-cores were embedded in paraffin, sectioned into 4 lm-thick slides and stained with hematoxylin and eosin (H&E) for histopathology evaluation. Correlations of the mean displacement between CT pre and CT needle with the presence or absence of malignant cells in the inked biopsy core were investigated. It is important to note that all 12 patients were found positive for malignancy from evaluation based on multiple cores but the ink-marked cores only were used for correlation between image misregistration and biopsy adequacy.
2.F. Motion correction of PET images
To correct the initial PET scan for intraprocedural patient and organ motion, the DVF calculated from CT pre and CT needle registration was applied to PET pre . The obtained PET is referred to as PET corrected . This motion correction method was tested on the eleven patients for whom two PET scans (before and after needle insertion) were acquired. PET corrected was compared to the reference image, PET needle . To quantify this correction, the three PET image datasets (PET pre , PET needle , PET corrected ) were segmented using the Fuzzy Locally Adaptive Bayesian (FLAB) algorithm. The FLAB algorithm is based on a fuzzy C-means clustering algorithm and Bayesian probability. It has been shown to be independent of the anatomical site and to be accurate, robust, and reproducible. [16] [17] [18] [19] The segmentation contours obtained for patient 12 for the three PET scans and the distance d between the middle of the biopsy needle notch and the center of mass of the segmentation contour for CT needle /PET needle are shown in Fig. 3 . The distance d of each segmented contour was measured on the fused CT needle /PET pre, CT needle / PET needle, CT needle /PET corrected images [ Fig. 4(b) ].
RESULTS
3.A. Image displacement
Image registration using the fast-free form deformable registration took less than 3 min. The algorithm seemed to perform well in the vicinity of the needle and not to be affected by the difference of resolution and noise between CT pre and CT needle . For the 19 patients included in this study, the mean displacement over a region of interest defined around the needle as obtained from the CT deformation vector field was 5.1 mm (with min = 1.1 mm, max = 10.9 mm and standard deviation = 3.0 mm).
3.B. Biopsy adequacy
The presence or absence of malignant cells in the inked biopsy specimen as a function of the mean displacement between CT pre and CT needle is shown in Table I . It shows that above a threshold of 7.2 mm the core obtained did not contain any malignant cells whereas the PET pre /CT needle image showed the needle to be in the FDG-avid lesion. For a mean displacement of 6.2 mm and under, the biopsy yielded a true-positive result.
3.C. Motion correction
The position of the centers of gravity of the segmented PET regions and their distances from the needle notch were used to evaluate the registration errors of the PET images. For the eleven patients with a second PET, the mean areas of the segmented regions in the slice of interest containing the needle for PET pre , PET corrected , and PET needle were, respectively, 1 Fig. 4 are plotted the differences in the distances between the needle notch and the center of gravity of the PET avid area in the reference image, CT needle /PET needle , and the respective distances in CT needle /PET pre versus that difference for CT needle /PET corrected . If the deformation correction applied to PET pre is accurate, the difference in the distance between CT needle /PET needle and CT needle /PET corrected will be smaller than the difference in the distance between CT needle /PET needle and CT needle /PET pre . Hence, every point above the line x=y shows that applying the deformation correction to PET pre image makes it closer to the reference image. Figure 4 shows that in 8 of 11 cases, applying the deformation correction to PET pre reduces the registration error. For two cases, no improvement was observed and for one case the registration error is 1 mm higher after correction.
DISCUSSION
The goal of this study was to determine the registration error between the PET scan acquired at the beginning of the procedure and the CT acquired with the needle in place, to develop a correction for it and to evaluate how misregistration affects biopsy outcome. Our findings indicate that PET/CT misregistration leads to false-negative biopsy results above a certain registration error threshold. The mean needle displacement resulting from such misregistration could be calculated automatically after CT needle acquisition and made available to the interventional radiologist. The interventional radiologist can then decide whether the registration is accurate and reliable or whether a second PET should be acquired. The displacement threshold leading to false negative results was estimated to be 7.2 mm from a small patient cohort and needs to be refined using a larger number of cases. This threshold is in agreement with previously published numbers. In a study of 267 patients undergoing a lung biopsy guided by a preprocedural FDG PET/CT and for whom good registration with the procedural CT was obtained, the distance between the needle tip and the area with the highest metabolic activity was 15.4 AE 14 mm for patients with false negative results compared to 5.9 AE 13.4 mm for patients with true positive results. 3 The mean displacements between CT pre and CT needle over a ROI around the needle can be attributed to patient motion between the two CT scans, or organ displacement due to pressure from the needle insertion. Areas of the body that are most subject to respiratory and cardiac motion are mainly the organs of the thorax and abdomen, [20] [21] [22] which correspond to the organs biopsied for the patients included in this study. A study performed by Shyn et al. report that during PET/CT-guided biopsy or ablation of lesions located near the diaphragm, mean misregistration in the transverse plane was 2.6 mm (range, 0-8 mm) with monitoring respiratory motion and 4.0 mm (range, 0-12 mm) without monitoring. 12 PET and CT have different accumulation times (less than a minute for the CT and several minutes for the PET), which may introduce motion blurring and distortion of moving lesions imaged by PET. If the lesion is moving over a breathing cycle, the PET image will be the integration over time of the activity detected at each location, increasing the apparent size of the lesion. 23 The challenges faced when trying to register CT pre and CT needle come from the presence of the biopsy needle in CT needle and not in CT pre and the difference in resolution and noise level between the two images. The deformable image registration used in this study showed good performance with this particular type of data. The objective function for deformable registration includes a regularization term for the displacement field that penalizes the deviation of displacement vectors of neighboring voxels. Using a multiresolution paradigm also provides for a smooth displacement field. Moving the voxels corresponding to the needle in the CT in which the needle is not present does not significantly affect the intensity in the objective function, but affects the smoothness of the displacement field. Thus, the needle voxels tend to move with the movement of the surrounding soft tissue. In addition, due to the regularization term and the use of multiresolution approach the algorithm is not sensitive to noise.
The method proposed for motion correction can be applied in real time in order to obtain a more accurate PET/ CT registration without the burden of an additional PET scan acquisition. When using this technique, improvements were observed in 8 out of 11 cases. The lack of improvement in three cases may be due to: (a) motion between the acquisition of CT needle and PET needle ; (b) the difference in the uptake period between PET pre and PET needle , which can be about an hour and could result in different FDG uptake in the lesion; (c) performance limitations of the fast free-form algorithm. Testing the method on a larger patient cohort is needed before using it clinically.
PET needle /CT needle was considered as the reference image but motion can occur between the PET needle and the CT needle acquisition, since they are acquired sequentially. 24 The chances for motion between PET needle and CT needle are, however, less compared to PET pre /CT pre since PET needle and CT needle are acquired for a shorter length of time. One way to verify position of the needle in PET needle would be to visualize the biopsy needle in the PET image. A similar approach was investigated and reported by Prior et al. for a patient undergoing a PET/CT-guided radiofrequency ablation of liver metastases. 25 A 20-gauge cannula filled with 18 F-FDG was inserted into the wider coaxial cannula used to insert the radiofrequency electrode in the lesion. The radioactive cannula was visible on both the PET and the CT images. The location of the radiofrequency electrode probe in the PET image could therefore be determined accurately by extrapolation of the trajectory of the 18 F-filled cannula. As stated in the method section, PET needle was corrected for photon attenuation using CT pre , since CT needle was acquired with a lower dose and poorer quality and the presence of the needle in the CT needle makes the latter suboptimal for attenuation-correction. This implies that when motion occurs between the two acquisitions, the attenuation correction will introduce quantitative errors in the PET needle image. 26 One way of testing if using CT pre introduces quantification error in PET needle would be to apply the deformation vector field to CT pre and to reconstruct PET needle with the corrected CT pre . However, we expect the attenuation correction error to be low for lesions located in organs which like the liver have homogeneous density and the attenuation is uniform.
Finally, we mention that while we have been using our standard PET reconstruction protocol (128 9 128 image matrix), a PET/CT biopsy PET reconstruction specific protocol using a finer reconstruction matrix (e.g., 256 9 256) would allow to more accurately identify the position of the biopsy needle in the PET image.
CONCLUSIONS
The deformation vector field obtained from registering the CT acquired at the beginning of the procedure to the CT with the needle in place, allows for evaluation of the error in needle placement with respect to the metabolic center of the lesion for real time PET/CT guided biopsy procedures. It may also be considered for a correction of the PET images and to evaluate if a second PET is needed, however, further validation with more patients is needed in order to recommend this approach. The magnitude of the deformation vector field was shown to correlate with inadequate biopsy samples. 
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